Skip to Main Content

Wednesday Afternoon Lecture Series (WALS) - Human pluripotent stem cells: the new patient?

January 25, 2017

3:00pm - 4:00pm

The NIH Director's Wednesday Afternoon Lecture Series, colloquially known as WALS, is the highest-profile lecture program at the NIH. Lectures occur on most Wednesdays from September through June from 3:00 to 4:00 p.m. in Masur Auditorium, Building 10 on the NIH Bethesda campus.

Each season includes some of the biggest names in biomedical and behavioral research. The goal of the WALS is to keep NIH researchers abreast of the latest and most important research in the United States and beyond. An added treat is the annual J. Edward Rall Cultural Lecture, which features top authors and other cultural icons. All speakers are nominated by the NIH community.

Speaker: Christine Mummery, Ph.D.

Derivation of many different cell types from human pluripotent stem cells (embryonic stem cells or HESCs and induced pluripotent stem cells or hiPS cells) is an area of growing interest both for potential cell therapy and as a platform for drug discovery and toxicity. Most particularly, the recent availability of methods to introduce specific disease mutations into human pluripotent stem cells and/or to derive these cells as hiPS cells by reprogramming from any patient of choice, are creating unprecedented opportunities to create disease models “in a dish” and study ways to treat it or slow down its rate of development. We produce isogenic pairs of hiPSC lines to compare diseased and corresponding healthy cardiomyocytes and vascular endothelial cells and identify disease related phenotypes and mechanisms. We have shown in hiPSC-cardiomyocytes that mutations in ion channel genes can accurately predict changes in cardiac electrical properties and reveal drug sensitivities observed in patients. Similar studies will be described using vascular endothelial cells from hPSC. Relevant in all cases is the development of appropriate bioassays in which to measure disease phenotypes which may be highly cell type specific dependent. For heart cells, this might be electrical activity or contractions force; for vascular cells, responses to fluid flow flow and inflammation. Various approaches to this will be presented.

Building 10, Clinical Center, Masur Auditorium

For further information go to: https://oir.nih.gov/wals/2016-2017/human-pluripotent-stem-cells-new-patient